Related Experiment Video
Updated: Jul 6, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
Multiple pathways regulated by the tumor suppressor PP2A in transformation
Jukka Westermarck1, William C Hahn
1Institute of Medical Technology, University of Tampere and Tampere University Hospital, 33520 Tampere, Finland.
Abstract:
Reversible protein phosphorylation plays a central role in regulating intracellular signaling. Dysregulation of the mechanisms that regulate phosphorylation plays a direct role in cancer initiation and maintenance. Although abundant evidence supports the role of kinase oncogenes in cancer development, recent work has illuminated the role of specific protein phosphatases in malignant transformation. Protein phosphatase 2A (PP2A) is the major serine-threonine phosphatase in mammalian cells. Inactivation of PP2A by viral oncoproteins, mutation of specific subunits or overexpression of endogenous inhibitors contributes to cell transformation by regulating specific phosphorylation events. Here, we review recent progress in our understanding of how PP2A regulates mitogenic signaling pathways in cancer pathogenesis and how PP2A activity is modulated in human cancers.
Insights
Protein phosphatase 2A (PP2A) inactivation contributes to cancer by altering cell signaling. This review covers PP2A
Area of Science:
- Molecular biology
- Cellular signaling
- Cancer research
Background:
- Reversible protein phosphorylation is crucial for intracellular signaling.
- Dysregulation of phosphorylation mechanisms contributes to cancer initiation and progression.
- While oncogenic kinases are well-studied, protein phosphatases also play significant roles in malignancy.
Purpose of the Study:
- To review the role of Protein phosphatase 2A (PP2A) in cancer pathogenesis.
- To elucidate how PP2A regulates mitogenic signaling pathways in cancer.
- To discuss the modulation of PP2A activity in human cancers.
Main Methods:
- Literature review of recent scientific progress.
- Analysis of PP2A's role in regulating phosphorylation events.
- Examination of PP2A inactivation mechanisms in cancer.
Main Results:
- PP2A is the primary serine-threonine phosphatase in mammalian cells.
- Inactivation of PP2A, through viral oncoproteins, mutations, or inhibitors, promotes cell transformation.
- PP2A regulates key mitogenic signaling pathways implicated in cancer.
Conclusions:
- PP2A inactivation is a significant factor in cancer development.
- Understanding PP2A's regulatory mechanisms in cancer is critical for therapeutic strategies.
- Further research into PP2A modulation in human cancers is warranted.
Related Concept Videos
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...